PECAM1 and diabetes mellitus: in vivo studies have shown that endothelial cells or platelet derived-MPs impair angiogenesis, reduce cerebral microvascular density and accelerate the progression and severity of retinopathy in DM; meanwhile, MPs, especially CD31+ MPs, mediated EC dysfunction in ex vivo studies [10-12].